USA

Following the initial high growth phase of the pandemic in 2020, and subsequent slowdown in growth in 2021 as panic-buying receded, dietary supplements has re-entered a period of consistency, and is set to continue to grow at a moderate pace in…

2022 brought closure to many of the lasting pandemic-driven behaviours impacting dermatologicals, such as mask-wearing, an extreme focus on sanitisation, and remaining social distancing practices in large settings. Yet, the year also presented new…

In 2023, cough, cold and allergy (hay fever) remedies is set to see dynamic current growth, on top of an extremely strong performance in 2022. Within the category, after medicated confectionery, growth is set to be driven by and paediatric cough/cold…

While 2022 was characterised by high inflation, persisting supply chain constraints, and the ongoing war in Ukraine, which brought price increases and volume declines across much of consumer health, it benefited from waning COVID-19 cases and the…

There are interesting developments in terms of diverging performances within adult systemic analgesics. In 2023, acetaminophen is set to drive current value growth, and significantly outpace the overall performance of adult analgesics. Growth in…